Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. Its solutions enable more than 38,000 healthcare providers between the United States and Canada and power owned and operated healthcare ecosystem in Canada with over 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States its solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL Health USA Patient and Provider Services consists of four assets: CRH Medical, Provider Staffing, Circle Medical and Wisp. It provides cybersecurity protection and patient data privacy solutions.


TSX:WELL - Post by User

Comment by jdsd0517on Apr 26, 2022 2:18pm
80 Views
Post# 34632999

RE:RE:RE:The effect of rate hikes...

RE:RE:RE:The effect of rate hikes...WELL isn't really a digital health stock.  They are a digital health stock like Canadian Tire is an ecommerce play, only around the edges.

Pure plays are generally valued higher.  That said, I have no opinion on Teledoc at this point, and my opinion on WELL is well documented here.  Which, for the record is:
  • I don't hate the company, I believe it is structurally overly complicated to "manage numbers" to show continued growth.  The acquisitions at the corporate level appear opportunistic, though the ones at the subsidiary level look more disciplined;
  • Based on DCF, I think that WELL is fully valued. 
  • The one point that I make that could be seen as "bashing" is that I see "penny stock pumper" behaviour from WELL.  In particular, odd press releases from a company that purports to be grown up (earnings pre-releases and untimely earnings releases).  Whenever I have seen this in the past, it has never ended well. 
Noshortsallowed wrote: You don't have an answer then. What do you say to the investor who wants to invest in digital healthcare in a "high" interest rate market and they are looking at Teledoc with projected -1.60 EPS for 2022 and WELL which is projected to be positive EPS this year with merely one quarter the revenue of that company which is more than 10x our market cap. Which is the better buy in with interest rates as horrifying as they are for you?


<< Previous
Bullboard Posts
Next >>